The new insight offered by this study is that an entire cascade of SLE-associated events, including transcriptional, cellular, serological, and clinical manifestations, can be triggered, independent of antigen presentation, by a short epitope coded by allele DRB1*03:01, known as a major risk factor in human SLE. Here, HLA-DRB1 is linked to systemic lupus erythematosus.